Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Quantitative Susceptibility Mapping Indicates a Disturbed Brain Iron Homeostasis in Neuromyelitis Optica - A Pilot Study.
Efficacy of hematopoietic stem cell formultiple sclerosis, an evidence based meta-analysis.
Hippocampal expressions of metallothionein I/II and glycoprotein 96 in EAE-prone and EAE-resistant strains of rats.
Multidisciplinary rehabilitation and steroids in the management of multiple sclerosis relapses: a randomized controlled trial.
High-resolution characterisation of the aging brain using simultaneous quantitative susceptibility mapping (QSM) and R2* measurements at 7T.
A rare case of SPG11 mutation with multiple sclerosis.
The role of geographical ecological studies in identifying diseases linked to UVB exposure and/or vitamin D.
Evaluation of quality of life in individuals with severe chronic motor disability: A major challenge.
Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis.
Patterns of Use of Tests to Monitor Disease Activity Among Patients With Relapsing Remitting Multiple Sclerosis in the United States and Europe.
Multiple sclerosis: Bigger brains resist disability in MS.
Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells.
Factors Associated with Caregiver's Burden in Relapsing-Remitting Multiple Sclerosis and Satisfaction with Current Therapies. MS-Feeling Study.
Understanding walking activity in multiple sclerosis: step count, walking intensity and uninterrupted walking activity duration related to degree of disability.
A triple-effect cocktail produced by neural stem cells as a novel neurorepair therapy for chronic stage CNS autoimmunity.
All relapsing multiple sclerosis patients should be seen in specialist clinics - NO.
Determinants of High Cost in Multiple Sclerosis Patients: A Claims and Chart Review Study.
Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.
All relapsing multiple sclerosis patients should be managed at a specialist clinic - Commentary.
Caveolin-1 Is Critical for Lymphocyte Trafficking into Central Nervous System during Experimental Autoimmune Encephalomyelitis.
Analysis of Expenditure in Multiple Sclerosis Disease Modifying Therapies Evolution Between 2004-2013 in Spain.
Prescribed psychiatric medication among multiple sclerosis patients before and after disability pension: a register study with matched controls.
Leptin and other adipokines in EAE and MS
MAL Is a Regulator of the Recruitment of Myelin Protein PLP to Membrane Microdomains.
Cognitive Impairment and Health Related Quality of Life in Relapsing Remitting Multiple Sclerosis.
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »